February 15, 2018 / 7:39 AM / 3 months ago

BRIEF-Promore Pharma Regains Rights For Pxl01 Manufacturing

Feb 15 (Reuters) - PROMORE PHARMA AB:

* PROMORE PHARMA REGAINS RIGHTS FOR PXL01 MANUFACTURING

* WILL ASSUME RESPONSIBILITY FOR MANUFACTURING OF INVESTIGATIONAL MEDICINAL PRODUCT FOR CLINICAL PHASE III TRIAL FOR PXL01 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below